newswire

Summit Therapeutics U.S. stocks fell more than 11% in pre-market trading

2026-07-22·newswire-us-stock-195640

Summit Therapeutics U.S. stocks fell more than 11% in pre-market trading.

On July 22, Summit Therapeutics (SMMT) U.S. stocks fell more than 11% before the market opened, now trading at $13.0.

#Stocks #Markets

Full text

Summit Therapeutics U.S. stocks fell more than 11% in pre-market trading

On July 22, Summit Therapeutics (SMMT) U.S. stocks fell more than 11% before the market opened, now trading at $13.0.

← Back to archive